Related Experiment Videos
[Paradoxical radiologic progression despite appropriate anti-tuberculous therapy]
Uğur Gönlügür1, Sule Koşar, Arzu Mirici
1Çanakkale Onsekiz Mart University Faculty of Medicine, Department of Chest Diseases, Çanakkale, Turkey. gonlugur@gmail.com
Mikrobiyoloji Bulteni
|May 29, 2012
Summary
Paradoxical response in tuberculosis involves clinical worsening despite treatment. This case highlights that temporary radiological worsening can occur during appropriate anti-tuberculosis therapy, emphasizing microbiological monitoring.
Area of Science:
- Pulmonology
- Infectious Diseases
- Medical Case Reports
Background:
- Paradoxical response, defined as clinical or radiological deterioration during appropriate anti-tuberculosis therapy, presents diagnostic challenges.
- This phenomenon holds both medical and legal significance due to difficulties in identification.
- Tuberculosis remains a prevalent public health concern, necessitating a thorough understanding of treatment responses.
Observation:
- A 68-year-old, Human Immunodeficiency Virus (HIV)-negative male presented with symptoms of active pulmonary tuberculosis.
- Initial chest CT revealed lung opacities; diagnosis was confirmed by acid-fast bacilli in sputum.
- Despite a standard four-drug regimen, the patient experienced initial radiological deterioration at one month.
Findings:
- No evidence of endobronchial lesions or persistent infection was found via bronchoscopy and lavage.
- The anti-tuberculosis therapy regimen remained unchanged.
- Gradual radiological regression of pulmonary infiltrates was observed, indicating a paradoxical response.
Implications:
- Temporary radiological worsening can occur in pulmonary tuberculosis patients undergoing appropriate anti-tuberculosis therapy.
- Microbiological monitoring is the gold standard for assessing treatment efficacy, surpassing radiological assessment.
- Differential diagnosis must consider comorbid conditions, drug reactions, patient compliance, and treatment failure.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations: